SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001626199-23-000118
Filing Date
2023-11-08
Accepted
2023-11-07 20:18:57
Documents
16
Period of Report
2023-11-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alpn-20231106.htm   iXBRL 8-K 43101
2 EX-1.1 alpn-ex11xunderwritingagre.htm EX-1.1 229088
3 EX-4.1 alpn-ex41xformofprefundedw.htm EX-4.1 91681
4 EX-5.1 alpn-ex51opinionfollowxon2.htm EX-5.1 17052
8 image_0.jpg GRAPHIC 74541
  Complete submission text file 0001626199-23-000118.txt   689512

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alpn-20231106.xsd EX-101.SCH 1953
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alpn-20231106_lab.xml EX-101.LAB 24851
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alpn-20231106_pre.xml EX-101.PRE 13084
10 EXTRACTED XBRL INSTANCE DOCUMENT alpn-20231106_htm.xml XML 2827
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37449 | Film No.: 231385607
SIC: 2834 Pharmaceutical Preparations